TY - JOUR
T1 - Altered erythrocyte C3b receptor expression, immune complexes, and complement activation in homosexual men in varying risk groups for acquired immune deficiency syndrome
AU - Tausk, F. A.
AU - McCutchan, J. A.
AU - Spechko, P.
AU - Schreiber, R. D.
AU - Gigli, I.
PY - 1986
Y1 - 1986
N2 - We studied levels of erythrocyte C3b receptors (E-CR1) and correlated them to the level of circulating immune complexes (CIC) and complement activation in patients with or at risk for acquired immunodeficiency syndrome (AIDS). A significant reduction was found in patients with AIDS (185 ± 93 CR1/cell), AIDS-related complex, and generalized lymphadenopathy, whereas healthy male homosexuals or normal controls had 434 ± 193 and 509 ± 140 CR1/cell, respectively (P < 0.001). Family studies indicate that this defect is acquired. Reduction in E-CR1 was associated with increased levels of CIC when assayed by binding to Raji cells, but not when tested by C1q binding. Complement activation was assessed by levels of C3bi/C3d-g in plasma, measured with a monoclonal antibody specific for a neoantigen in C3d. AIDS patients had increased C3 activation (2.68 ± 1.67%) when compared with normal controls (0.9 ± 0.22%) (P < 0.01). The decreased E-CR1, the presence of CIC, and C3 activation suggest that complement activation by immune complexes may play a role in the clinical expression of the disease.
AB - We studied levels of erythrocyte C3b receptors (E-CR1) and correlated them to the level of circulating immune complexes (CIC) and complement activation in patients with or at risk for acquired immunodeficiency syndrome (AIDS). A significant reduction was found in patients with AIDS (185 ± 93 CR1/cell), AIDS-related complex, and generalized lymphadenopathy, whereas healthy male homosexuals or normal controls had 434 ± 193 and 509 ± 140 CR1/cell, respectively (P < 0.001). Family studies indicate that this defect is acquired. Reduction in E-CR1 was associated with increased levels of CIC when assayed by binding to Raji cells, but not when tested by C1q binding. Complement activation was assessed by levels of C3bi/C3d-g in plasma, measured with a monoclonal antibody specific for a neoantigen in C3d. AIDS patients had increased C3 activation (2.68 ± 1.67%) when compared with normal controls (0.9 ± 0.22%) (P < 0.01). The decreased E-CR1, the presence of CIC, and C3 activation suggest that complement activation by immune complexes may play a role in the clinical expression of the disease.
UR - http://www.scopus.com/inward/record.url?scp=0022999142&partnerID=8YFLogxK
U2 - 10.1172/JCI112688
DO - 10.1172/JCI112688
M3 - Article
C2 - 2944915
AN - SCOPUS:0022999142
SN - 0021-9738
VL - 78
SP - 977
EP - 982
JO - Journal of Clinical Investigation
JF - Journal of Clinical Investigation
IS - 4
ER -